Kyle Seamon

5PUBLICATIONS
106CO-AUTHORS
Molecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 22, 2026
Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer.

|Jun 22, 2026
Selective Inhibition of KRASG13C Reveals an Increased Dependence on Wild-Type RAS Isoforms in Codon 13 RAS-Mutant Cancers.

|Jul 24, 2025
A neomorphic protein interface catalyzes covalent inhibition of RAS<sup>G12D</sup> aspartic acid in tumors.

Caroline Weller, G Leslie Burnett, Lingyan Jiang

|Apr 09, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers.

Jingjing Jiang, Lingyan Jiang, Benjamin J Maldonato

|Aug 17, 2023
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS.

Christopher J Schulze, Kyle J Seamon, Yulei Zhao

Pageof 1

Frequent Collaborators

5 joint publications

Jacqueline A M Smith

4 joint publications

Matthew Holderfield

4 joint publications

Elena S Koltun

4 joint publications

Mallika Singh